Eli Lilly Steps Up Pharmacogenetics Effort
By Sally Mardikian PhD
Pharma Deals Review: Vol 2008 Issue 102 (Table of Contents)
Published: 6 Nov-2008
DOI: 10.3833/pdr.v2008.i102.109 ISSN: 1756-7874
Section: Licensing
Fulltext:
Abstract
Eli Lilly’s commitment to personalised medicine is demonstrated with its latest agreement with pharmacogenetics company, Cabernet Pharmaceuticals...
This page is available to subscribers only.
Not a subscriber? Join here
Already Registered? Please login using the top left purple box.
Copyright: © IQVIA 2018
RSS